Drug price hikes can damage company reputations, White House says amid EpiPen furor 1 234 567

Drug price hikes can damage company reputations, White House says amid EpiPen furor

cbc.ca

The White House on Wednesday said pharmaceutical firms risked damaging their reputations with big price hikes, but it sidestepped commenting directly on Mylan NV's decision to raise the price of its severe allergy treatment drug EpiPen.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567